Current Studies

Thank you for your interest in being a part of the clinical studies conducted by Eye Specialty Group!  Below you will find a brief description of each study and ways to find out if you qualify to participate.  If you have any questions related to our clinical studies, please contact Eye Specialty Group at 901-685-2200 or email us at research@esg.md.

Current Studies

Spectrum 3: Glaucoma or Ocular Hypertension Patients

A Phase III Study assessing the efficacy and safety of DE-117 Ophthalmic Solution compared with Timolol Maleate Ophthalmic Solution 0.5% in subjects with Glaucoma or Ocular Hypertension

For more information on this study, please click here.

Spectrum 5: Open-Angle Glaucoma or Ocular Hypertension Patients

An open-label, multicenter study assessing the efficacy and safety of DE-117 Ophthalmic Solution 0.002% in Latanoprost low/non-responder subjects diagnosed with primary open-angle Glaucoma or Ocular Hypertension.

For more information on this study, please click here.

Surface C-201-001: Cataract Surgery Patients

A multicenter, randomized, double-masked study to compare the ocular safety, tolerability, and efficacy of Surf-201 Ophthalmic Solution (0.2% Betamethasone Sodium Phosphate) to vehicle in Cataract Surgery subjects.

For more information on this study, please click here.

Triton: Open-Angle Glaucoma or Ocular Hypertension Patients

Evaluation of the duration of the effect of Bimatoprost SR in patients with open-angle Glaucoma or Ocular Hypertension.

For more information on this study, please click here.

For more information, fill out this form or call us at 901-685-2200.